164 related articles for article (PubMed ID: 32011065)
1. Efficacy of frameless stereotactic radiotherapy for the treatment of presumptive canine intracranial gliomas: A retrospective analysis (2014-2017).
Moirano SJ; Dewey CW; Haney S; Yang J
Vet Comp Oncol; 2020 Dec; 18(4):528-537. PubMed ID: 32011065
[TBL] [Abstract][Full Text] [Related]
2. Definitive-intent uniform megavoltage fractioned radiotherapy protocol for presumed canine intracranial gliomas: retrospective analysis of survival and prognostic factors in 38 cases (2013-2019).
Debreuque M; De Fornel P; David I; Delisle F; Ducerveau MN; Devauchelle P; Thibaud JL
BMC Vet Res; 2020 Oct; 16(1):412. PubMed ID: 33129320
[TBL] [Abstract][Full Text] [Related]
3. Survival times in dogs with presumptive intracranial gliomas treated with oral lomustine: A comparative retrospective study (2008-2017).
Moirano SJ; Dewey CW; Wright KZ; Cohen PW
Vet Comp Oncol; 2018 Dec; 16(4):459-466. PubMed ID: 29797768
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of stereotactic radiation therapy for the treatment of confirmed or presumed canine glioma.
Trageser E; Martin T; Burdekin B; Hart C; Leary D; LaRue S; Boss MK
Vet Comp Oncol; 2023 Dec; 21(4):578-586. PubMed ID: 37423611
[TBL] [Abstract][Full Text] [Related]
5. Frameless stereotactic radiotherapy alone and combined with temozolomide for presumed canine gliomas.
Dolera M; Malfassi L; Bianchi C; Carrara N; Finesso S; Marcarini S; Mazza G; Pavesi S; Sala M; Urso G
Vet Comp Oncol; 2018 Mar; 16(1):90-101. PubMed ID: 28643878
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic radiation therapy for treatment of canine intracranial meningiomas.
Griffin LR; Nolan MW; Selmic LE; Randall E; Custis J; LaRue S
Vet Comp Oncol; 2016 Dec; 14(4):e158-e170. PubMed ID: 25524449
[TBL] [Abstract][Full Text] [Related]
7. Primary irradiation of canine intracranial masses.
Spugnini EP; Thrall DE; Price GS; Sharp NJ; Munana K; Page RL
Vet Radiol Ultrasound; 2000; 41(4):377-80. PubMed ID: 10955504
[TBL] [Abstract][Full Text] [Related]
8. Outcome After Radiation Therapy in Canine Intracranial Meningiomas or Gliomas.
MagalhÃes TR; BenoÎt J; NÉČovÁ S; North S; Queiroga FL
In Vivo; 2021; 35(2):1117-1123. PubMed ID: 33622909
[TBL] [Abstract][Full Text] [Related]
9. CyberKnife stereotactic radiotherapy for treatment of primary intracranial tumors in dogs.
Carter GL; Ogilvie GK; Mohammadian LA; Bergman PJ; Lee RP; Proulx DR
J Vet Intern Med; 2021 May; 35(3):1480-1486. PubMed ID: 33755255
[TBL] [Abstract][Full Text] [Related]
10. Association of magnetic resonance imaging-based preoperative tumor volume with postsurgical survival time in dogs with primary intracranial glioma.
MacLellan JD; Arnold SA; Dave AC; Hunt MA; Pluhar GE
J Am Vet Med Assoc; 2018 Jan; 252(1):98-102. PubMed ID: 29244602
[TBL] [Abstract][Full Text] [Related]
11. Perfusion and Volume Response of Canine Brain Tumors to Stereotactic Radiosurgery and Radiotherapy.
Zwingenberger AL; Pollard RE; Taylor SL; Chen RX; Nunley J; Kent MS
J Vet Intern Med; 2016 May; 30(3):827-35. PubMed ID: 27149650
[TBL] [Abstract][Full Text] [Related]
12. Impact of radiation dose and pre-treatment pain levels on survival in dogs undergoing radiotherapy with or without chemotherapy for presumed extremity osteosarcoma.
Nolan MW; Green NA; DiVito EM; Lascelles BDX; Haney SM
Vet Comp Oncol; 2020 Dec; 18(4):538-547. PubMed ID: 32048435
[TBL] [Abstract][Full Text] [Related]
13. Definitive-intent intensity-modulated radiation therapy provides similar outcomes to those previously published for definitive-intent three-dimensional conformal radiation therapy in dogs with primary brain tumors: A multi-institutional retrospective study.
Van Asselt N; Christensen N; Meier V; Rohrer Bley C; Laliberte S; Poirier VJ; Desai N; Chen Y; Turek M
Vet Radiol Ultrasound; 2020 Jul; 61(4):481-489. PubMed ID: 32356907
[TBL] [Abstract][Full Text] [Related]
14. Hypofractionated radiation therapy of brain masses in dogs: a retrospective analysis of survival of 83 cases (1991-1996).
Brearley MJ; Jeffery ND; Phillips SM; Dennis R
J Vet Intern Med; 1999; 13(5):408-12. PubMed ID: 10499721
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic radiation therapy for canine multilobular osteochondrosarcoma: Eight cases.
Sweet KA; Nolan MW; Yoshikawa H; Gieger TL
Vet Comp Oncol; 2020 Mar; 18(1):76-83. PubMed ID: 30989784
[TBL] [Abstract][Full Text] [Related]
16. Safety and feasibility of stereotactic radiotherapy using computed portal radiography for canine intracranial tumors.
Rancilio NJ; Bentley RT; Plantenga JP; Parys MM; Crespo BG; Moore GE
Vet Radiol Ultrasound; 2018 Mar; 59(2):212-220. PubMed ID: 29205634
[TBL] [Abstract][Full Text] [Related]
17. Frameless stereotactic radiosurgery for the treatment of primary intracranial tumours in dogs.
Mariani CL; Schubert TA; House RA; Wong MA; Hopkins AL; Barnes Heller HL; Milner RJ; Lester NV; Lurie DM; Rajon DA; Friedman WA; Bova FJ
Vet Comp Oncol; 2015 Dec; 13(4):409-23. PubMed ID: 24007303
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of stereotactic body radiation therapy (SBRT) for the treatment of canine thyroid carcinoma.
Lee BI; LaRue SM; Seguin B; Griffin L; Prebble A; Martin T; Leary D; Boss MK
Vet Comp Oncol; 2020 Dec; 18(4):843-853. PubMed ID: 32515526
[TBL] [Abstract][Full Text] [Related]
19. Linac-based stereotactic radiation therapy for canine non-lymphomatous nasal tumours: 29 cases (2013-2016).
Gieger TL; Nolan MW
Vet Comp Oncol; 2018 Mar; 16(1):E68-E75. PubMed ID: 28741887
[TBL] [Abstract][Full Text] [Related]
20. Treatment outcomes and target delineation utilizing CT and MRI in 13 dogs treated with a uniform stereotactic radiation therapy protocol (16 Gy single fraction) for pituitary masses: (2014-2017).
Gieger TL; Nolan MW
Vet Comp Oncol; 2021 Mar; 19(1):17-24. PubMed ID: 32548944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
